Cg Oncology (CGON): Director sold, ~$28K

~$28K
Approx. value · 1,000 sh @ $28.00

Traded: Sep 3, 2025
Filed: Sep 4, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Jul 17, 2025InsiderDirector sold ~$56K of CGON shares in the open market
Sep 3, 2025 · this disclosureInsiderDirector sold ~$28K of CGON shares in the open market

What came next

Sep 3, 2025Insider · 1 personInsiders: 4 sales (~$2.8M)
Sep 5, 2025Insider · 1 personInsiders: 4 sales (~$852K)
Sep 11, 2025Insider · First insider buy since Jan 2024Director purchased ~$50M of CGON shares in the open market
Sep 15, 2025InsiderDirector sold ~$35K of CGON shares in the open market
Sep 18, 2025InsiderDirector sold ~$746K of CGON shares in the open market
Sep 19, 2025InsiderDirector sold ~$139K of CGON shares in the open market
Sep 29, 2025InsiderDirector sold ~$500K of CGON shares in the open market
Nov 10, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 10, 2025, Robert Lapetina, interim principal financial and accounting officer of CG Oncology, Inc. (the “ Company ”) delivered to the Company a notice of resignation from his position as interim principal financial and accounting officer of the Company.”
Nov 14, 2025Company filing · Form 8-K · ResultsReported its results
Nov 22, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On November 22, 2025, the Board of Directors (the “ Board ”) of CG Oncology, Inc. (the “ Company ”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Christina Rossi to the Company’s Board, effective November 24, 2025.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cg Oncology

For Cg Oncology, OQRO holds 4 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CGON page.

Other disclosures at Cg Oncology

Everything OQRO holds on this company is on its CGON page.

Cg Oncology (CGON)Director sold ~$28K

The story around this disclosure

What came next

How to read SEC Form 4

What else is on file for Cg Oncology

Other recent filings by Leonard E Post, Director

How this filing works

Other disclosures at Cg Oncology

This is one filing. OQRO holds the rest